首页 > 最新文献

Journal of veterinary emergency and critical care最新文献

英文 中文
Issue Information - Prelim 发行信息 - 初稿
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-06-14 DOI: 10.1111/vec.13305
{"title":"Issue Information - Prelim","authors":"","doi":"10.1111/vec.13305","DOIUrl":"https://doi.org/10.1111/vec.13305","url":null,"abstract":"","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"205-208"},"PeriodicalIF":1.3,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/vec.13305","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141326773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suspected cerebral salt wasting syndrome secondary to traumatic brain injury in a dog 疑似脑盐耗损综合征,继发于一只狗的脑外伤。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-29 DOI: 10.1111/vec.13375
Amanda E. Chromiak DVM, MS, Joanna Finstad DVM, MS, Edward Cooper VMD, MS, DACVECC

Objective

To describe a dog with suspected cerebral salt wasting syndrome (CSWS) secondary to traumatic brain injury (TBI).

Case Summary

A 2-month-old intact male Chihuahua-American Pitbull Terrier mix weighing 1.94 kg presented to a veterinary teaching emergency room after suffering bite wound-penetrating trauma to the head. Treatment was initiated with hyperosmotic agents, fluid resuscitation, and analgesia. The dog's neurologic dysfunction warranted hospitalization and continuous monitoring. Within 24 hours, the dog developed hyponatremia (133 mmol/L compared to 143 mmol/L on presentation [reference interval 142–149 mmol/L]). As the dog had concurrent tachycardia, increase in urine sodium concentration, polyuria, and weight loss, a diagnosis of cerebral salt wasting was suspected. A 2% hypertonic saline constant rate infusion was administered for volume replacement, and the patient showed improvement in clinical signs and blood sodium concentration. The dog was discharged on Day 5. Recheck examination showed significant neurologic improvement with sodium just below the low end of the reference range (141 mmol/L [reference interval 142–149 mmol/L]).

New or Unique Information Provided

This is the first description of suspected CSWS in veterinary medicine. Hyponatremia is a common finding in critically ill neurologic people, including those with TBI, and is typically associated with either syndrome of inappropriate antidiuretic hormone or CSWS. As treatment recommendations for syndrome of inappropriate antidiuretic hormone and CSWS are diametrically opposed, identifying the presence of hyponatremia and distinguishing between these 2 clinical entities is critical for improving patient care for those with TBI. This case highlights the characteristics and clinical progression regarding the diagnosis and management of suspected CSWS.

目的:描述一只继发性脑外伤(TBI)后疑似患有脑盐耗损综合征(CSWS)的犬:病例摘要:一只 2 个月大的完整雄性吉娃娃-美国比特斗牛梗混血犬,体重 1.94 千克,在头部遭受咬伤-穿透性外伤后被送往兽医教学急诊室。治疗开始时使用了高渗剂、液体复苏和镇痛剂。由于该犬神经功能失调,需要住院并接受持续监测。24 小时内,该犬出现低钠血症(133 毫摩尔/升,而发病时为 143 毫摩尔/升[参考区间 142-149 毫摩尔/升])。由于该犬同时伴有心动过速、尿钠浓度升高、多尿和体重减轻,因此被怀疑诊断为脑性盐耗竭。患者的临床症状和血钠浓度均有所改善。该犬在第 5 天出院。复查显示神经系统症状明显改善,血钠浓度略低于参考值范围的低端(141 mmol/L [参考值范围 142-149 mmol/L]):这是兽医学领域首次描述疑似 CSWS。低钠血症是神经系统重症患者(包括创伤性脑损伤患者)的常见症状,通常与抗利尿激素不当综合征或CSWS有关。由于抗利尿激素不当综合征和 CSWS 的治疗建议截然相反,因此识别低钠血症的存在并区分这两种临床实体对于改善 TBI 患者的护理至关重要。本病例强调了疑似 CSWS 诊断和管理的特征和临床进展。
{"title":"Suspected cerebral salt wasting syndrome secondary to traumatic brain injury in a dog","authors":"Amanda E. Chromiak DVM, MS,&nbsp;Joanna Finstad DVM, MS,&nbsp;Edward Cooper VMD, MS, DACVECC","doi":"10.1111/vec.13375","DOIUrl":"10.1111/vec.13375","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To describe a dog with suspected cerebral salt wasting syndrome (CSWS) secondary to traumatic brain injury (TBI).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Summary</h3>\u0000 \u0000 <p>A 2-month-old intact male Chihuahua-American Pitbull Terrier mix weighing 1.94 kg presented to a veterinary teaching emergency room after suffering bite wound-penetrating trauma to the head. Treatment was initiated with hyperosmotic agents, fluid resuscitation, and analgesia. The dog's neurologic dysfunction warranted hospitalization and continuous monitoring. Within 24 hours, the dog developed hyponatremia (133 mmol/L compared to 143 mmol/L on presentation [reference interval 142–149 mmol/L]). As the dog had concurrent tachycardia, increase in urine sodium concentration, polyuria, and weight loss, a diagnosis of cerebral salt wasting was suspected. A 2% hypertonic saline constant rate infusion was administered for volume replacement, and the patient showed improvement in clinical signs and blood sodium concentration. The dog was discharged on Day 5. Recheck examination showed significant neurologic improvement with sodium just below the low end of the reference range (141 mmol/L [reference interval 142–149 mmol/L]).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> New or Unique Information Provided</h3>\u0000 \u0000 <p>This is the first description of suspected CSWS in veterinary medicine. Hyponatremia is a common finding in critically ill neurologic people, including those with TBI, and is typically associated with either syndrome of inappropriate antidiuretic hormone or CSWS. As treatment recommendations for syndrome of inappropriate antidiuretic hormone and CSWS are diametrically opposed, identifying the presence of hyponatremia and distinguishing between these 2 clinical entities is critical for improving patient care for those with TBI. This case highlights the characteristics and clinical progression regarding the diagnosis and management of suspected CSWS.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"285-290"},"PeriodicalIF":1.3,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of medication and raw food use among canine blood donors 犬类献血者药物和生食使用情况调查。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-29 DOI: 10.1111/vec.13381
Marie K. Holowaychuk DVM, DACVECC

Background

Blood donors are screened for medication use to determine their health status and to ensure that the collection will be safe and efficacious for transfusion. Although stringent medication deferral guidelines exist for human blood donors, no consensus exists as to which medications should be permitted among canine donors.

Methods

A brief survey regarding canine donor screening methods was distributed to an online hematology and transfusion medicine group and included questions pertaining to commonly prescribed medications and consumption of a raw food diet.

Key Findings

The survey results demonstrate that more than half of the respondents accept canine donors given thyroid supplements, whereas respondents were split as to whether they accept canine donors given antihistamines chronically. Most survey respondents exclude canine donors taking anti-inflammatory or anti-itch medications unless in acute circumstances and only after a washout period. More than half of the survey respondents exclude dogs fed a raw food diet.

Significance

The survey results demonstrate that there is no obvious agreement regarding which medications to permit in canine donors. Evidence-based guidelines are needed to inform best practices and the subsequent decisions made by donor programs.

背景:对献血者进行用药筛查是为了确定他们的健康状况,并确保采血安全有效。虽然人类献血者有严格的药物使用限制准则,但对于犬类献血者应允许使用哪些药物,目前尚无共识:方法:我们向一个在线血液学和输血医学小组分发了一份关于犬类献血者筛选方法的简短调查,其中包括与常用处方药和生食有关的问题:调查结果显示,半数以上的受访者接受服用甲状腺补充剂的犬类捐赠者,而对于是否接受长期服用抗组胺药的犬类捐赠者,受访者意见不一。大多数调查对象不接受服用消炎或止痒药物的犬类捐献者,除非是在急性情况下,而且必须经过一段时间的冲洗。半数以上的调查对象不接受生食犬:调查结果表明,在允许犬类捐献者使用哪些药物的问题上并没有达成明显的一致。我们需要以证据为基础的指南,为最佳实践和捐献计划的后续决策提供参考。
{"title":"A survey of medication and raw food use among canine blood donors","authors":"Marie K. Holowaychuk DVM, DACVECC","doi":"10.1111/vec.13381","DOIUrl":"10.1111/vec.13381","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Blood donors are screened for medication use to determine their health status and to ensure that the collection will be safe and efficacious for transfusion. Although stringent medication deferral guidelines exist for human blood donors, no consensus exists as to which medications should be permitted among canine donors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A brief survey regarding canine donor screening methods was distributed to an online hematology and transfusion medicine group and included questions pertaining to commonly prescribed medications and consumption of a raw food diet.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Key Findings</h3>\u0000 \u0000 <p>The survey results demonstrate that more than half of the respondents accept canine donors given thyroid supplements, whereas respondents were split as to whether they accept canine donors given antihistamines chronically. Most survey respondents exclude canine donors taking anti-inflammatory or anti-itch medications unless in acute circumstances and only after a washout period. More than half of the survey respondents exclude dogs fed a raw food diet.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Significance</h3>\u0000 \u0000 <p>The survey results demonstrate that there is no obvious agreement regarding which medications to permit in canine donors. Evidence-based guidelines are needed to inform best practices and the subsequent decisions made by donor programs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"302-306"},"PeriodicalIF":1.3,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective evaluation of a right heart parameter score in the assessment of precapillary pulmonary hypertension in dogs (2017–2021): 135 cases 在评估犬毛细血管前肺动脉高压时对右心参数评分的回顾性评估(2017-2021 年):135例
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-29 DOI: 10.1111/vec.13394
Rebecca R. Gelé DVM, Priscilla Burnotte DVM, Annelies Valcke DVM, Thomas G. Walker DVM, DACVECC, Christopher R. Kennedy BVetMed, DACVECC, Anne-Christine Merveille DMV, PhD, DECVIM, Kris Gommeren DVM, PhD, DECVIM, DECVECC
<div> <section> <h3> Objective</h3> <p>To determine if emergency and critical care residents can identify moderate to severe precapillary pulmonary hypertension on cardiologist-obtained cineloops using a pulmonary hypertension score (PHS) and report the interobserver variability of the PHS.</p> </section> <section> <h3> Design</h3> <p>Multicenter, retrospective, case–control study from 2017 to 2021.</p> </section> <section> <h3> Setting</h3> <p>Private referral center and veterinary teaching hospital.</p> </section> <section> <h3> Animals</h3> <p>One hundred and thirty-five client-owned dogs that underwent diagnostic echocardiography.</p> </section> <section> <h3> Interventions</h3> <p>None.</p> </section> <section> <h3> Measurements and Main Results</h3> <p>Medical records of dogs with stage B1 myxomatous mitral valve disease (MMVD) and dogs diagnosed with precapillary pulmonary hypertension (PCPH) via echocardiograms were reviewed. Dogs were categorized by a cardiologist into 5 groups (normal, B1 MMVD, mild, moderate, and severe PCPH) based on Doppler pulmonary pressure gradients and right heart morphology. Cineloops from each case were subjectively evaluated by emergency and critical care residents for the presence of right atrial and ventricular enlargement, right ventricular hypertrophy, interventricular septal flattening, and pulmonary artery and trunk enlargement to form a composite pulmonary hypertension score out of 8 (PHS8). When available, signs of peritoneal effusion and distention of the caudal vena cava were subjectively assessed to generate a pulmonary hypertension score out of 10 (PHS10). There was excellent discrimination of moderate to severe PCPH versus grouped absent to mild PCPH using PHS8 (area under the receiver operator curve [AUC] [95% confidence interval, CI] = 0.90 [0.84–0.95], <i>P </i>< 0.0001) and PHS10 (AUC [95% CI] = 0.89 [0.81–0.97], <i>P </i>< 0.0001). PHS8 ≥3 was 64% sensitive and 98% specific for moderate to severe PCPH (positive likelihood ratio [LR+] 32, negative likelihood ration [LR−] 0.37). PHS10 ≥ 3.3 was 64% sensitive and 92% specific for moderate to severe PCPH (LR+ 8, LR− 0.39). Interobserver agreement was good to excellent (intraclass correlation coefficient [ICC] = 0.74 [95% CI: 0.66–0.80], <i>n</i> = 135).</p> </section> <section> <h3> Conclusions</h3> <p>Residents identified moderate to severe PCPH in dogs using PHS on cineloops previousl
目的:确定急诊和重症监护住院医师能否使用肺动脉高压评分(PHS)在心脏病专家获得的心电图上识别中度至重度毛细血管前肺动脉高压,并报告 PHS 的观察者间变异性:2017年至2021年的多中心、回顾性、病例对照研究:私立转诊中心和兽医教学医院:135只接受超声心动图诊断的客户自养犬:测量和主要结果对患有B1期肌瘤性二尖瓣病(MMVD)的犬和通过超声心动图诊断为毛细血管前肺动脉高压(PCPH)的犬的病历进行回顾。心脏病专家根据多普勒肺压力梯度和右心形态将狗分为 5 组(正常、B1 MMVD、轻度、中度和重度 PCPH)。急诊和重症监护住院医师对每个病例的 Cineloops 进行主观评估,以确定是否存在右心房和右心室增大、右心室肥厚、室间隔变平以及肺动脉和肺动脉干增大,从而得出肺动脉高压综合评分(满分 8 分,PHS8)。如果有腹腔积液和尾腔静脉膨胀的迹象,则对其进行主观评估,以得出肺动脉高压的满分 10 分(PHS10)。使用 PHS8 对中度至重度 PCPH 与分组缺失至轻度 PCPH 进行了很好的鉴别(接收器运算曲线下面积 [AUC] [95% 置信区间,CI] = 0.90 [0.84-0.95],P 结论):住院医师使用 PHS 对心脏科医生之前获得的心音环识别犬的中度至重度 PCPH。在有限的培训条件下,他们之间的一致性良好至极佳。有必要进行前瞻性研究,以确定住院医师能否获得 PHS 的诊断图像。
{"title":"Retrospective evaluation of a right heart parameter score in the assessment of precapillary pulmonary hypertension in dogs (2017–2021): 135 cases","authors":"Rebecca R. Gelé DVM,&nbsp;Priscilla Burnotte DVM,&nbsp;Annelies Valcke DVM,&nbsp;Thomas G. Walker DVM, DACVECC,&nbsp;Christopher R. Kennedy BVetMed, DACVECC,&nbsp;Anne-Christine Merveille DMV, PhD, DECVIM,&nbsp;Kris Gommeren DVM, PhD, DECVIM, DECVECC","doi":"10.1111/vec.13394","DOIUrl":"10.1111/vec.13394","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine if emergency and critical care residents can identify moderate to severe precapillary pulmonary hypertension on cardiologist-obtained cineloops using a pulmonary hypertension score (PHS) and report the interobserver variability of the PHS.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Multicenter, retrospective, case–control study from 2017 to 2021.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Private referral center and veterinary teaching hospital.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Animals&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;One hundred and thirty-five client-owned dogs that underwent diagnostic echocardiography.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Interventions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;None.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Measurements and Main Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Medical records of dogs with stage B1 myxomatous mitral valve disease (MMVD) and dogs diagnosed with precapillary pulmonary hypertension (PCPH) via echocardiograms were reviewed. Dogs were categorized by a cardiologist into 5 groups (normal, B1 MMVD, mild, moderate, and severe PCPH) based on Doppler pulmonary pressure gradients and right heart morphology. Cineloops from each case were subjectively evaluated by emergency and critical care residents for the presence of right atrial and ventricular enlargement, right ventricular hypertrophy, interventricular septal flattening, and pulmonary artery and trunk enlargement to form a composite pulmonary hypertension score out of 8 (PHS8). When available, signs of peritoneal effusion and distention of the caudal vena cava were subjectively assessed to generate a pulmonary hypertension score out of 10 (PHS10). There was excellent discrimination of moderate to severe PCPH versus grouped absent to mild PCPH using PHS8 (area under the receiver operator curve [AUC] [95% confidence interval, CI] = 0.90 [0.84–0.95], &lt;i&gt;P &lt;/i&gt;&lt; 0.0001) and PHS10 (AUC [95% CI] = 0.89 [0.81–0.97], &lt;i&gt;P &lt;/i&gt;&lt; 0.0001). PHS8 ≥3 was 64% sensitive and 98% specific for moderate to severe PCPH (positive likelihood ratio [LR+] 32, negative likelihood ration [LR−] 0.37). PHS10 ≥ 3.3 was 64% sensitive and 92% specific for moderate to severe PCPH (LR+ 8, LR− 0.39). Interobserver agreement was good to excellent (intraclass correlation coefficient [ICC] = 0.74 [95% CI: 0.66–0.80], &lt;i&gt;n&lt;/i&gt; = 135).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Residents identified moderate to severe PCPH in dogs using PHS on cineloops previousl","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"277-284"},"PeriodicalIF":1.3,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective evaluation of the effects of a single intraoperative dose of dexamethasone in horses undergoing exploratory laparotomy for small intestinal lesions (2008–2019): 240 cases 对因小肠病变而接受探查性开腹手术的马匹术中单次剂量地塞米松效果的回顾性评估(2008-2019年):240例。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-29 DOI: 10.1111/vec.13374
Rose E. Tallon MA, VetMB, MVetMed, DACVIM, Sarah E. Allen BVetMed, MSc PhD, Bruce M. Bladon BVM&S, DESTS, DECVS, Kate F. McGovern BVetMed, MS DACVIM, DECEIM
<div> <section> <h3> Objective</h3> <p>To determine the effect of a single intraoperative dose of dexamethasone on the risk of postoperative reflux (POR) in horses undergoing small intestinal surgery and to investigate its association with incisional complications and short-term survival.</p> </section> <section> <h3> Design</h3> <p>Retrospective cohort study over an 11-year period (2008–2019).</p> </section> <section> <h3> Setting</h3> <p>UK-based private referral center.</p> </section> <section> <h3> Animals</h3> <p>Two hundred and forty client-owned horses >6 months of age undergoing exploratory laparotomy for treatment of a small intestinal lesion.</p> </section> <section> <h3> Interventions</h3> <p>Ninety-seven horses received a single intraoperative dose of dexamethasone (0.1 mg/kg, IV).</p> </section> <section> <h3> Measurements and Main Results</h3> <p>Of 97 horses that received dexamethasone, 52 (53.6%) required small intestinal resection. Of 143 horses that did not receive dexamethasone, small intestinal resection was performed in 78 (54.5%). A total of 70 horses (29%) developed POR. There was no difference in the risk of POR between horses that received dexamethasone (25/97; 26%) and those that did not (45/143; 31%, <i>P </i>= 0.34). Risk factors associated with the development of POR included small intestinal resection (odds ratio [OR]: 4.55, 95% confidence interval [CI]: 2.27–9.11, <i>P </i>< 0.001), a PCV >40% 24 hours postoperatively (OR: 4.11, 95% CI: 2–8.45, <i>P </i>< 0.001), and a WBC count >10 × 10<sup>9</sup>/L on admission (OR: 3.29, 95% CI: 1.47–7.41, <i>P </i>= 0.004). Dexamethasone was not associated with the odds of POR. Horses undergoing repeat laparotomy had a higher risk of incisional infection (OR: 8.07, 95% CI: 1.98–32.81, <i>P</i> = 0.004). Dexamethasone administration was not associated with incisional infection. The development of POR was negatively associated with short-term survival (OR: 0.07, 95% CI: 0.03–0.17, <i>P</i> ≤ 0.001). Dexamethasone administration was not retained in the final multivariable model for survival.</p> </section> <section> <h3> Conclusions</h3> <p>Intraoperative dexamethasone was not associated with the development of POR in this study population, nor did it have an effect on postoperative survival or incisional infection in horses undergoing surgical management of small intestinal disease.</p> </section>
目的确定术中单次使用地塞米松对接受小肠手术的马匹术后反流(POR)风险的影响,并研究其与切口并发症和短期存活率的关系:设计:11 年间(2008-2019 年)的回顾性队列研究:地点:英国私立转诊中心:240匹年龄大于6个月的客户饲养的马匹接受探查性开腹手术,以治疗小肠病变:97匹马在术中接受了单剂量地塞米松(0.1毫克/千克,静脉注射):在接受地塞米松治疗的97匹马中,52匹(53.6%)需要进行小肠切除术。在 143 匹未接受地塞米松治疗的马中,78 匹(54.5%)需要进行小肠切除术。共有70匹马(29%)发生了POR。接受地塞米松治疗的马匹(25/97;26%)和未接受地塞米松治疗的马匹(45/143;31%,P = 0.34)发生POR的风险没有差异。与发生 POR 相关的风险因素包括小肠切除术(几率比 [OR]:4.55,95% 置信区间[CI]:2.27-9.11,P 40% 术后 24 小时(OR:4.11,95% CI:2-8.45,P 10 × 109/L 入院时(OR:3.29,95% CI:1.47-7.41,P = 0.004)。地塞米松与 POR 的几率无关。再次接受开腹手术的马发生切口感染的风险较高(OR:8.07,95% CI:1.98-32.81,P = 0.004)。地塞米松的使用与切口感染无关。POR的发生与短期存活率呈负相关(OR:0.07,95% CI:0.03-0.17,P≤0.001)。地塞米松未被纳入最终的生存率多变量模型:结论:在这项研究中,术中使用地塞米松与POR的发生无关,对接受小肠疾病手术治疗的马匹的术后存活率或切口感染也没有影响。
{"title":"Retrospective evaluation of the effects of a single intraoperative dose of dexamethasone in horses undergoing exploratory laparotomy for small intestinal lesions (2008–2019): 240 cases","authors":"Rose E. Tallon MA, VetMB, MVetMed, DACVIM,&nbsp;Sarah E. Allen BVetMed, MSc PhD,&nbsp;Bruce M. Bladon BVM&S, DESTS, DECVS,&nbsp;Kate F. McGovern BVetMed, MS DACVIM, DECEIM","doi":"10.1111/vec.13374","DOIUrl":"10.1111/vec.13374","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine the effect of a single intraoperative dose of dexamethasone on the risk of postoperative reflux (POR) in horses undergoing small intestinal surgery and to investigate its association with incisional complications and short-term survival.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Retrospective cohort study over an 11-year period (2008–2019).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;UK-based private referral center.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Animals&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Two hundred and forty client-owned horses &gt;6 months of age undergoing exploratory laparotomy for treatment of a small intestinal lesion.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Interventions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Ninety-seven horses received a single intraoperative dose of dexamethasone (0.1 mg/kg, IV).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Measurements and Main Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Of 97 horses that received dexamethasone, 52 (53.6%) required small intestinal resection. Of 143 horses that did not receive dexamethasone, small intestinal resection was performed in 78 (54.5%). A total of 70 horses (29%) developed POR. There was no difference in the risk of POR between horses that received dexamethasone (25/97; 26%) and those that did not (45/143; 31%, &lt;i&gt;P &lt;/i&gt;= 0.34). Risk factors associated with the development of POR included small intestinal resection (odds ratio [OR]: 4.55, 95% confidence interval [CI]: 2.27–9.11, &lt;i&gt;P &lt;/i&gt;&lt; 0.001), a PCV &gt;40% 24 hours postoperatively (OR: 4.11, 95% CI: 2–8.45, &lt;i&gt;P &lt;/i&gt;&lt; 0.001), and a WBC count &gt;10 × 10&lt;sup&gt;9&lt;/sup&gt;/L on admission (OR: 3.29, 95% CI: 1.47–7.41, &lt;i&gt;P &lt;/i&gt;= 0.004). Dexamethasone was not associated with the odds of POR. Horses undergoing repeat laparotomy had a higher risk of incisional infection (OR: 8.07, 95% CI: 1.98–32.81, &lt;i&gt;P&lt;/i&gt; = 0.004). Dexamethasone administration was not associated with incisional infection. The development of POR was negatively associated with short-term survival (OR: 0.07, 95% CI: 0.03–0.17, &lt;i&gt;P&lt;/i&gt; ≤ 0.001). Dexamethasone administration was not retained in the final multivariable model for survival.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Intraoperative dexamethasone was not associated with the development of POR in this study population, nor did it have an effect on postoperative survival or incisional infection in horses undergoing surgical management of small intestinal disease.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 ","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"245-251"},"PeriodicalIF":1.3,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019–2021): 98 cases 回顾性评估休克指数对确定患有肌瘤性二尖瓣疾病的犬是否存在充血性心力衰竭的实用性(2019-2021):98例
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-29 DOI: 10.1111/vec.13379
Hannah Matson BVetMed, Efa A. Llewellyn BVetMed, DACVECC, DECVECC

Objectives

To calculate the shock index (SI) in dogs with myxomatous mitral valve disease (MMVD) and to evaluate its use to predict the presence of congestive heart failure (CHF).

Design

Retrospective study.

Setting

Small animal university veterinary teaching hospital.

Animals

Ninety-eight dogs with MMVD and 20 healthy dogs as part of a control group.

Interventions

Heart rate (HR) and systolic blood pressure (SBP) were recorded, and SI was calculated by dividing HR by SBP for each dog.

Measurements and Main Results

The mean (SD) HR, SBP, and SI were 123/min (32.6), 147 mm Hg (21.5), and 0.86 (0.3), respectively, for dogs with MMVD and 98/min (20.9), 145 mm Hg (18.7), and 0.68 (0.13), respectively, for control dogs. Dogs with MMVD had a significantly higher HR compared with control dogs (< 0.01), and an elevation in HR was seen as the severity of MMVD increased. Dogs in stage B2 and C/D MMVD had a significantly higher SI value compared with control dogs (= 0.04 and P < 0.01, respectively). SI was significantly higher in dogs in stage C/D MMVD compared with dogs in stage B2 MMVD (< 0.01). Ten of 98 (10%) dogs had an arrhythmia. HR, SBP, and SI were not significantly different between dogs with and without arrhythmias (= 0.13, = 0.57, and = 0.07, respectively), but significantly more dogs with CHF had an arrhythmia (= 0.01). SI (area under the curve [AUC]: 0.98) and HR (AUC: 0.95) were excellent indicators for the presence of CHF. An optimal SI cutoff value ≥1.1 had 92% sensitivity and 95% specificity for predicting the presence of CHF, and an optimal HR cutoff value of ≥157/min had 92% sensitivity and 93% specificity for the prediction of CHF.

Conclusions

When there are compatible clinical signs, SI values ≥1.1 may suggest the presence of CHF in dogs with MMVD.

目的:计算肌瘤性二尖瓣病犬的休克指数(SI),并评估其在预测充血性心力衰竭(CHF)中的应用:计算患有肌瘤性二尖瓣疾病(MMVD)的犬的休克指数(SI),并评估其在预测充血性心力衰竭(CHF)中的应用:设计:回顾性研究:动物:98 只患有 MMVD 的狗:98只患有MMVD的狗和20只作为对照组的健康狗:记录心率(HR)和收缩压(SBP),用每只狗的心率除以收缩压计算SI:患有 MMVD 的狗的平均(标清)心率、收缩压和 SI 分别为 123/min (32.6)、147 mm Hg (21.5) 和 0.86 (0.3);对照组狗的平均(标清)心率、收缩压和 SI 分别为 98/min (20.9)、145 mm Hg (18.7) 和 0.68 (0.13)。与对照组犬相比,患有 MMVD 的犬的心率明显更高(P 结论:MMVD 患者的心率明显高于对照组犬:当临床症状相符时,SI 值≥1.1 可能提示 MMVD 患犬存在 CHF。
{"title":"Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019–2021): 98 cases","authors":"Hannah Matson BVetMed,&nbsp;Efa A. Llewellyn BVetMed, DACVECC, DECVECC","doi":"10.1111/vec.13379","DOIUrl":"10.1111/vec.13379","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To calculate the shock index (SI) in dogs with myxomatous mitral valve disease (MMVD) and to evaluate its use to predict the presence of congestive heart failure (CHF).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Small animal university veterinary teaching hospital.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>Ninety-eight dogs with MMVD and 20 healthy dogs as part of a control group.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>Heart rate (HR) and systolic blood pressure (SBP) were recorded, and SI was calculated by dividing HR by SBP for each dog.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>The mean (SD) HR, SBP, and SI were 123/min (32.6), 147 mm Hg (21.5), and 0.86 (0.3), respectively, for dogs with MMVD and 98/min (20.9), 145 mm Hg (18.7), and 0.68 (0.13), respectively, for control dogs. Dogs with MMVD had a significantly higher HR compared with control dogs (<i>P </i>&lt; 0.01), and an elevation in HR was seen as the severity of MMVD increased. Dogs in stage B2 and C/D MMVD had a significantly higher SI value compared with control dogs (<i>P </i>= 0.04 and <i>P</i> &lt; 0.01, respectively). SI was significantly higher in dogs in stage C/D MMVD compared with dogs in stage B2 MMVD (<i>P </i>&lt; 0.01). Ten of 98 (10%) dogs had an arrhythmia. HR, SBP, and SI were not significantly different between dogs with and without arrhythmias (<i>P </i>= 0.13, <i>P </i>= 0.57, and <i>P </i>= 0.07, respectively), but significantly more dogs with CHF had an arrhythmia (<i>P </i>= 0.01). SI (area under the curve [AUC]: 0.98) and HR (AUC: 0.95) were excellent indicators for the presence of CHF. An optimal SI cutoff value ≥1.1 had 92% sensitivity and 95% specificity for predicting the presence of CHF, and an optimal HR cutoff value of ≥157/min had 92% sensitivity and 93% specificity for the prediction of CHF.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>When there are compatible clinical signs, SI values ≥1.1 may suggest the presence of CHF in dogs with MMVD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"231-237"},"PeriodicalIF":1.3,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of coagulation and fibrinolysis in Irish Wolfhounds and age-matched control dogs using tissue plasminogen activator-augmented viscoelastic testing 使用组织凝血酶原激活剂增强粘弹性测试,比较爱尔兰猎狼犬和年龄匹配的对照犬的凝血和纤维蛋白溶解情况。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-22 DOI: 10.1111/vec.13385
Samantha Davis DVM, Daniel J. Fletcher PhD, DVM, DACVECC, Ashley Newman DVM, Marjory B. Brooks DVM, DACVIM
<div> <section> <h3> Objective</h3> <p>To determine if Irish Wolfhounds (IWs), like other sighthounds, are hyperfibrinolytic compared with nonsighthound dogs using 2 native and tissue plasminogen activator (tPA)-enhanced viscoelastic assays, one that is whole blood-based (viscoelastic coagulation monitor [VCM]) and the other that is plasma-based thromboelastography (TEG).</p> </section> <section> <h3> Design</h3> <p>Cohort study.</p> </section> <section> <h3> Setting</h3> <p>University teaching hospital.</p> </section> <section> <h3> Animals</h3> <p>A convenience sample of 27 IWs recruited from the Irish Wolfhound Association of New England Specialty and the local community, and 27 healthy, age-matched, large-breed control dogs.</p> </section> <section> <h3> Interventions</h3> <p>None.</p> </section> <section> <h3> Measurements and Main Results</h3> <p>Blood samples including CBC, biochemistry, traditional coagulation, and viscoelastic testing were collected from IWs and control dogs. Twelve IWs had viscoelastic testing. IWs had lower fibrinogen concentrations (215.5 ± 57.8 vs 251.4 ± 64.5 mg/dL, <i>P</i> = 0.034) and formed weaker clots on both whole-blood VCM and plasma TEG assays (maximum clot firmness [VCM-MCF] = 39.4 [25.1–48.8] vs 48.5 [34.6–57.3], <i>P </i>= 0.0042; maximum amplitude [TEG-MA] = 22.7 [14.7–33.6] vs 32.2 [26.9–42.0], <i>P</i> < 0.0001). IWs were hyperfibrinolytic compared with control dogs on VCM whole-blood assays, with 25 U/mL tPA (lysis at 30 min [VCM-LI30] = 68.1 [0–100] vs 99.9 [63.3–100], <i>P</i> = 0.0009; lysis at 45 min [VCM-LI45] = 31.0 [0–100] vs 98.1 [38.4–100], <i>P</i> = 0.0002) but hypofibrinolytic compared with controls on TEG plasma assays with 50 U/mL tPA (lysis at 30 min [TEG-LY30] = 45.7 [4.6–94.6] vs 93.7 [12.3–96.5], <i>P</i> = 0.0004; lysis at 60 min [TEG-LY60] = 68.7 [29.7–96.8] vs 95.7 [34.4–97.6], <i>P</i> = 0.0003). Minimal fibrinolysis was measured on whole-blood VCM or plasma TEG assays without the addition of tPA, and there were no differences between the 2 groups.</p> </section> <section> <h3> Conclusions</h3> <p>Weaker clots were found in IWs than control dogs. With the addition of tPA, IWs had evidence of hyperfibrinolysis on whole-blood VCM assays and hypofibrinolysis on plasma TEG assays compared with control dogs. Without the addition of tPA, however, both groups of dogs showed minimal fibrinolysis on viscoelastic testing.</p>
目的:使用两种原生和组织纤溶酶原激活剂(tPA)增强型粘弹性检测方法(一种是基于全血的粘弹性凝血监测仪(VCM),另一种是基于血浆的血栓弹性成像(TEG)),确定爱尔兰猎狼犬(IWs)是否与其他八哥犬一样,具有高纤维蛋白溶解性:设计:队列研究:动物干预措施:无:测量和主要结果从爱尔兰猎狼犬和对照组犬只身上采集血液样本,包括全血细胞计数、生物化学、传统凝血和粘弹性测试。12 只 IW 接受了粘弹性测试。IWs 的纤维蛋白原浓度较低(215.5 ± 57.8 vs 251.4 ± 64.5 mg/dL,P = 0.034),在全血 VCM 和血浆 TEG 检测中形成的凝块较弱(最大凝块坚固度 [VCM-MCF] = 39.4 [25.1-48.8] vs 48.5 [34.6-57.3],P = 0.0042;最大振幅[TEG-MA] = 22.7 [14.7-33.6] vs 32.2 [26.9-42.0],P 结论):与对照组犬相比,IW犬体内发现的血凝块更弱。与对照组犬相比,在添加了 tPA 后,IW 在全血 VCM 检测中显示出高纤维蛋白溶解,而在血浆 TEG 检测中显示出低纤维蛋白溶解。然而,在不添加 tPA 的情况下,两组狗在粘弹性测试中的纤溶程度都很低。
{"title":"Comparison of coagulation and fibrinolysis in Irish Wolfhounds and age-matched control dogs using tissue plasminogen activator-augmented viscoelastic testing","authors":"Samantha Davis DVM,&nbsp;Daniel J. Fletcher PhD, DVM, DACVECC,&nbsp;Ashley Newman DVM,&nbsp;Marjory B. Brooks DVM, DACVIM","doi":"10.1111/vec.13385","DOIUrl":"10.1111/vec.13385","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To determine if Irish Wolfhounds (IWs), like other sighthounds, are hyperfibrinolytic compared with nonsighthound dogs using 2 native and tissue plasminogen activator (tPA)-enhanced viscoelastic assays, one that is whole blood-based (viscoelastic coagulation monitor [VCM]) and the other that is plasma-based thromboelastography (TEG).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Cohort study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;University teaching hospital.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Animals&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A convenience sample of 27 IWs recruited from the Irish Wolfhound Association of New England Specialty and the local community, and 27 healthy, age-matched, large-breed control dogs.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Interventions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;None.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Measurements and Main Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Blood samples including CBC, biochemistry, traditional coagulation, and viscoelastic testing were collected from IWs and control dogs. Twelve IWs had viscoelastic testing. IWs had lower fibrinogen concentrations (215.5 ± 57.8 vs 251.4 ± 64.5 mg/dL, &lt;i&gt;P&lt;/i&gt; = 0.034) and formed weaker clots on both whole-blood VCM and plasma TEG assays (maximum clot firmness [VCM-MCF] = 39.4 [25.1–48.8] vs 48.5 [34.6–57.3], &lt;i&gt;P &lt;/i&gt;= 0.0042; maximum amplitude [TEG-MA] = 22.7 [14.7–33.6] vs 32.2 [26.9–42.0], &lt;i&gt;P&lt;/i&gt; &lt; 0.0001). IWs were hyperfibrinolytic compared with control dogs on VCM whole-blood assays, with 25 U/mL tPA (lysis at 30 min [VCM-LI30] = 68.1 [0–100] vs 99.9 [63.3–100], &lt;i&gt;P&lt;/i&gt; = 0.0009; lysis at 45 min [VCM-LI45] = 31.0 [0–100] vs 98.1 [38.4–100], &lt;i&gt;P&lt;/i&gt; = 0.0002) but hypofibrinolytic compared with controls on TEG plasma assays with 50 U/mL tPA (lysis at 30 min [TEG-LY30] = 45.7 [4.6–94.6] vs 93.7 [12.3–96.5], &lt;i&gt;P&lt;/i&gt; = 0.0004; lysis at 60 min [TEG-LY60] = 68.7 [29.7–96.8] vs 95.7 [34.4–97.6], &lt;i&gt;P&lt;/i&gt; = 0.0003). Minimal fibrinolysis was measured on whole-blood VCM or plasma TEG assays without the addition of tPA, and there were no differences between the 2 groups.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Weaker clots were found in IWs than control dogs. With the addition of tPA, IWs had evidence of hyperfibrinolysis on whole-blood VCM assays and hypofibrinolysis on plasma TEG assays compared with control dogs. Without the addition of tPA, however, both groups of dogs showed minimal fibrinolysis on viscoelastic testing.&lt;/p&gt;\u0000 ","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"222-230"},"PeriodicalIF":1.3,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141077352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-care viscoelastic coagulation monitor parameters in Amazon parrots (Amazona spp.) 亚马逊鹦鹉(Amazona spp.)
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-18 DOI: 10.1111/vec.13386
Amanda Burke DVM, Miryam Reems DVM, DACVECC, Maria Spriggs DVM, PhD

Objective

To evaluate the feasibility of the point-of-care viscoelastic coagulation monitor (VCM) in Amazon parrots (Amazona spp.) and describe the parameters with fresh whole-blood samples in healthy Amazon parrots.

Design

A total of 18 Amazon parrots were enrolled. Physical examinations, a CBC, and a biochemistry profile, including bile acids, were performed on all parrots. VCM tracings were obtained at the time of venipuncture for baseline laboratory work.

Measurements and Main Results

The median clot time was 2102 seconds (range: 38.6–3599 s), median clot formation time was 929 seconds (range: 21.4–1711 s), median alpha angle was 20 (range: 6–67), and the median maximum clot formation was 8.5 (range: 0–36). The median lysis index at 30 minutes (LI30) was 100 (range: 98–100), and the median lysis index at 45 minutes (LI45) was 100 (range: 90–100). Of 18 samples, alpha angles were not reported in 7 samples, LI30 was not reported in 10 samples, and LI45 was not reported in 12 samples. Of the qualitative curves, 6 reflected normal mammalian curves, and the remainder were consistent with a hypocoaguable state.

Conclusions

The results were markedly variable, with the majority of VCM tracings being hypocoagulable in comparison with reference intervals established for dogs and cats. Using these protocols, the VCM is not reliable in Amazon parrots. Future areas of investigation include altering the temperature during sample analysis, the use of activators, or an exchange of clotting reagents for an extrinsic pathway activator, which may contribute to the success of this device in avian species.

目的:评估亚马逊鹦鹉(Amazonapp:评估亚马逊鹦鹉(Amazona spp.)护理点粘弹性凝血监测仪(VCM)的可行性,并描述健康亚马逊鹦鹉新鲜全血样本的参数:设计:共招募了 18 只亚马逊鹦鹉。设计:共招募了 18 只亚马逊鹦鹉,对所有鹦鹉进行了体格检查、全血细胞计数和生化分析(包括胆汁酸)。在静脉穿刺时采集 VCM 曲线,用于基线实验室工作:凝血时间中位数为 2102 秒(范围:38.6-3599 秒),凝血形成时间中位数为 929 秒(范围:21.4-1711 秒),α角中位数为 20(范围:6-67),凝血形成最大值中位数为 8.5(范围:0-36)。30 分钟裂解指数(LI30)的中位数为 100(范围:98-100),45 分钟裂解指数(LI45)的中位数为 100(范围:90-100)。在 18 个样本中,7 个样本未报告α角,10 个样本未报告 LI30,12 个样本未报告 LI45。在定性曲线中,有 6 个反映了哺乳动物的正常曲线,其余的则符合低凝状态:结论:结果差异明显,与为狗和猫建立的参考区间相比,大多数 VCM 曲线都处于低凝状态。使用这些方案,亚马逊鹦鹉的 VCM 并不可靠。未来的研究领域包括在样本分析过程中改变温度、使用激活剂或将凝血试剂换成外在途径激活剂,这可能有助于该设备在鸟类中取得成功。
{"title":"Point-of-care viscoelastic coagulation monitor parameters in Amazon parrots (Amazona spp.)","authors":"Amanda Burke DVM,&nbsp;Miryam Reems DVM, DACVECC,&nbsp;Maria Spriggs DVM, PhD","doi":"10.1111/vec.13386","DOIUrl":"10.1111/vec.13386","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the feasibility of the point-of-care viscoelastic coagulation monitor (VCM) in Amazon parrots (<i>Amazona</i> spp.) and describe the parameters with fresh whole-blood samples in healthy Amazon parrots.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>A total of 18 Amazon parrots were enrolled. Physical examinations, a CBC, and a biochemistry profile, including bile acids, were performed on all parrots. VCM tracings were obtained at the time of venipuncture for baseline laboratory work.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>The median clot time was 2102 seconds (range: 38.6–3599 s), median clot formation time was 929 seconds (range: 21.4–1711 s), median alpha angle was 20 (range: 6–67), and the median maximum clot formation was 8.5 (range: 0–36). The median lysis index at 30 minutes (LI30) was 100 (range: 98–100), and the median lysis index at 45 minutes (LI45) was 100 (range: 90–100). Of 18 samples, alpha angles were not reported in 7 samples, LI30 was not reported in 10 samples, and LI45 was not reported in 12 samples. Of the qualitative curves, 6 reflected normal mammalian curves, and the remainder were consistent with a hypocoaguable state.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The results were markedly variable, with the majority of VCM tracings being hypocoagulable in comparison with reference intervals established for dogs and cats. Using these protocols, the VCM is not reliable in Amazon parrots. Future areas of investigation include altering the temperature during sample analysis, the use of activators, or an exchange of clotting reagents for an extrinsic pathway activator, which may contribute to the success of this device in avian species.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"238-244"},"PeriodicalIF":1.3,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of hyperbaric oxygen therapy on snake-bite-associated wounds in dogs 高压氧疗法对狗被蛇咬伤相关伤口的影响。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-18 DOI: 10.1111/vec.13383
Shelly Olin DVM, DACVIM, Julie Schildt DVM, DACVECC, Michael Lane DVM, DACVIM, Adesola Odunayo DVM, MS, DACVECC, Cary Springer MS, Dana Call RVT, VTS (ECC), CHT-V, Selene Jones DACVD, DVM, Dennis Geiser DVM, CHT-V, DABVP, Daryl Millis DVM, DACVS, CCRP, Marti Drum DVM, PhD, CCRP, CERP

Objective

To assess the effect of hyperbaric oxygen therapy (HBOT) on Crotalinae envenomation-induced wound swelling and severity and pain in dogs, and to describe the safety and complications of HBOT.

Design

Prospective, randomized, controlled, blinded study (2017–2021).

Setting

University teaching hospital, private veterinary practice.

Animals

Thirty-six client-owned dogs presenting within 24 hours of a confirmed or suspected naturally occurring Crotalinae snake bite injury were enrolled between 2017 and 2021.

Interventions

In addition to the standard of care treatment, dogs received 2 interventions with either HBOT (n = 19) or control (n = 16) within 24 hours of hospital admission. Dogs receiving HBOT were pressurized over 15 minutes (1 psi/min), maintained at a target pressure of 2 atmosphere absolute (ATA) for 30 minutes, and decompressed over 15 minutes. Control dogs received 1 ATA for 1 hour. Local wound swelling, wound severity score, and pain score were assessed at admission, before and after each intervention, and at hospital discharge.

Measurements and Main Results

There was no significant difference in wound swelling (= 0.414), severity score (= 1.000), or pain score (= 0.689) between HBOT and control groups. Pain decreased significantly over time regardless of the study intervention (< 0.001). There were no major adverse effects associated with either study intervention.

Conclusions

HBOT did not significantly alter the short-term recovery from Crotalinae envenomation in this study population. However, the study might be underpowered to detect a significant treatment effect.

目的评估高压氧疗法(HBOT)对犬螫伤引起的伤口肿胀、严重程度和疼痛的影响,并描述高压氧疗法的安全性和并发症:前瞻性、随机对照、盲法研究(2017-2021年):大学教学医院、私人兽医诊所:在2017年至2021年期间,36只客户饲养的狗在24小时内出现确诊或疑似自然发生的克罗塔林科蛇咬伤.干预措施:除标准护理治疗外,犬只还在入院后 24 小时内接受了 HBOT(n = 19)或对照组(n = 16)的 2 次干预。接受 HBOT 治疗的狗在 15 分钟内加压(1 psi/min),在 2 个绝对大气压 (ATA) 的目标压力下维持 30 分钟,然后在 15 分钟内减压。对照组狗接受 1 ATA 加压 1 小时。在入院时、每次干预前后和出院时对局部伤口肿胀、伤口严重程度评分和疼痛评分进行评估:HBOT 组和对照组在伤口肿胀(P = 0.414)、伤口严重程度评分(P = 1.000)或疼痛评分(P = 0.689)方面无明显差异。随着时间的推移,疼痛明显减轻,而与研究干预无关(P 结论:HBOT 并未明显改变伤口的短期疗效:在这项研究的人群中,HBOT 并未明显改变 Crotalinae 中毒后的短期恢复情况。不过,这项研究的力量可能不足以检测出明显的治疗效果。
{"title":"The effects of hyperbaric oxygen therapy on snake-bite-associated wounds in dogs","authors":"Shelly Olin DVM, DACVIM,&nbsp;Julie Schildt DVM, DACVECC,&nbsp;Michael Lane DVM, DACVIM,&nbsp;Adesola Odunayo DVM, MS, DACVECC,&nbsp;Cary Springer MS,&nbsp;Dana Call RVT, VTS (ECC), CHT-V,&nbsp;Selene Jones DACVD, DVM,&nbsp;Dennis Geiser DVM, CHT-V, DABVP,&nbsp;Daryl Millis DVM, DACVS, CCRP,&nbsp;Marti Drum DVM, PhD, CCRP, CERP","doi":"10.1111/vec.13383","DOIUrl":"10.1111/vec.13383","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To assess the effect of hyperbaric oxygen therapy (HBOT) on <i>Crotalinae</i> envenomation-induced wound swelling and severity and pain in dogs, and to describe the safety and complications of HBOT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Prospective, randomized, controlled, blinded study (2017–2021).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>University teaching hospital, private veterinary practice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Animals</h3>\u0000 \u0000 <p>Thirty-six client-owned dogs presenting within 24 hours of a confirmed or suspected naturally occurring <i>Crotalinae</i> snake bite injury were enrolled between 2017 and 2021.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interventions</h3>\u0000 \u0000 <p>In addition to the standard of care treatment, dogs received 2 interventions with either HBOT (<i>n</i> = 19) or control (<i>n</i> = 16) within 24 hours of hospital admission. Dogs receiving HBOT were pressurized over 15 minutes (1 psi/min), maintained at a target pressure of 2 atmosphere absolute (ATA) for 30 minutes, and decompressed over 15 minutes. Control dogs received 1 ATA for 1 hour. Local wound swelling, wound severity score, and pain score were assessed at admission, before and after each intervention, and at hospital discharge.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Measurements and Main Results</h3>\u0000 \u0000 <p>There was no significant difference in wound swelling (<i>P </i>= 0.414), severity score (<i>P </i>= 1.000), or pain score (<i>P </i>= 0.689) between HBOT and control groups. Pain decreased significantly over time regardless of the study intervention (<i>P </i>&lt; 0.001). There were no major adverse effects associated with either study intervention.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>HBOT did not significantly alter the short-term recovery from <i>Crotalinae</i> envenomation in this study population. However, the study might be underpowered to detect a significant treatment effect.</p>\u0000 </section>\u0000 </div>","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"211-221"},"PeriodicalIF":1.3,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/vec.13383","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2024 RECOVER CPR Guidelines 2024 RECOVER CPR 指南。
IF 1.3 3区 农林科学 Q3 VETERINARY SCIENCES Pub Date : 2024-05-10 DOI: 10.1111/vec.13382
Jamie M. Burkitt-Creedon DVM, DACVECC, Manuel Boller Dr med vet, MTR, DACVECC, Daniel J. Fletcher PhD, DVM, DACVECC
{"title":"2024 RECOVER CPR Guidelines","authors":"Jamie M. Burkitt-Creedon DVM, DACVECC,&nbsp;Manuel Boller Dr med vet, MTR, DACVECC,&nbsp;Daniel J. Fletcher PhD, DVM, DACVECC","doi":"10.1111/vec.13382","DOIUrl":"10.1111/vec.13382","url":null,"abstract":"","PeriodicalId":17603,"journal":{"name":"Journal of veterinary emergency and critical care","volume":"34 3","pages":"307"},"PeriodicalIF":1.3,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140900520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of veterinary emergency and critical care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1